Sanofi Consumer Healthcare India Reports Strong Q1'26 Performance with 33% Revenue Growth
Article excerpt
Highlighted: the sentence this signal was extracted from
Sanofi Consumer Healthcare India delivered robust Q4FY26 performance with net profit surging 35.60% to ₹678 million and revenue growing 35.29% to ₹2,348 million. The company successfully relaunched previously recalled products and published its financial results in newspapers following SEBI compliance requirements. *this image is generated using AI for illustrative purposes only. Sanofi Consumer Healthcare India Limited has announced its unaudited financial results for the quarter ended March 31, 2026, demonstrating strong operational performance across key metrics. The Board of Directors approved the results during a meeting held on April 28, 2026, from 1:00 p.m. to 3:40 p.m. The company has submitted the required financial documentation to both BSE Limited and National Stock Exchange of India Limited, complying with SEBI Listing Regulations. The company delivered impressive financial results for Q4FY26, with net profit reaching ₹678 million compared to ₹500 million in the corresponding quarter of the previous year, representing a 35.60% year-over-year growth. Revenue grew to ₹2,348 million from ₹1,778 million, reflecting strong business momentum of 35.29% growth. Basic and diluted earnings per share (Rs. 10/- each) stood at ₹29.44 for Q4FY26, compared to ₹21.69 in the same quarter of the previous year. Total income from operations for the quarter ended March 31, 2026 was...
Keep reading with a free account
The rest of this article, and every signal for Sanofi, is in your free account.
